The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Polycythemia Vera (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Polycythemia Vera (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycythemia Vera - Drugs In Development, 2021, pr...
July 2021
142 pages
Psoriasis (Immunology) - Drugs In Development, 2021
US$ 2,500.00
Psoriasis (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Drugs In Development, 2021, provides an over...
July 2021
1178 pages
Radiation Toxicity - Drugs In Development, 2021
US$ 2,000.00
Radiation Toxicity - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Synd...
July 2021
337 pages
Rectal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Rectal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Drugs In Development, 2021, provides a...
July 2021
417 pages
Rhabdomyosarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Rhabdomyosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma - Drugs In Development, 2021, prov...
July 2021
662 pages
Rosacea (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Rosacea (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Drugs In Development, 2021, provides an overvie...
July 2021
107 pages
Synovial Sarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Synovial Sarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Drugs In Development, 2021, prov...
July 2021
539 pages
Tetanus (Infectious Disease) - Drugs In Development, 2021
US$ 2,000.00
Tetanus (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Drugs In Development, 2021, provides an...
July 2021
98 pages
Thalassemia (Hematology) - Drugs In Development, 2021
US$ 2,000.00
Thalassemia (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Drugs In Development, 2021, provides an...
July 2021
278 pages
Thyroid Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Thyroid Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer - Drugs In Development, 2021, provides...
July 2021
1423 pages
Type 2 Angiotensin II Receptor - Drugs In Development, 2021
US$ 3,500.00
Type 2 Angiotensin II Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Type 2 Angiotensin II Receptor - Drugs In Development, 2021'; Type 2 Angiotensin II Rece...
July 2021
57 pages
Uveal Melanoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Uveal Melanoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveal Melanoma - Drugs In Development, 2021, provides...
July 2021
545 pages
Uveitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Uveitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis - Drugs In Development, 2021, provides an overv...
July 2021
288 pages
Vitiligo (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Vitiligo (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Drugs In Development, 2021, provides an overv...
July 2021
203 pages
Investigation Report on China's Iohexol Market 2021-2025
US$ 2,600.00
Iohexol is a non-ionic X-ray contrast agent. Iohexol injection is suitable for intravascular and intracavitary injections in adults and children. In clinical angiography (cerebrovascular angiography,...
July 2021
50 pages
Investigation Report on China's Linezolid Market 2021-2025
US$ 2,600.00
Linezolid is an oxazolidinone antibiotic, mainly used to treat infections caused by gram-positive (G+) cocci, including suspected or confirmed hospital-acquired pneumonia (HAP) caused by methicillin-r...
July 2021
50 pages
Investigation Report on China's Metformin Market 2021-2025
US$ 2,600.00
Metformin is the first-line drug for the treatment of type 2 diabetes, especially in people who are overweight. Metformin was originally developed by Merck Sharp & Dohme (trade name: GLUCOPHAGE ). GLU...
July 2021
50 pages
Investigation Report on China's Nifedipine Market 2021-2025
US$ 2,600.00
Nifedipine is a dihydropyridine calcium channel blocker, which is mainly used to bind to L-type calcium channels. Nifedipine is mainly used to treat chronic stable angina pectoris, vasospasm angina pe...
July 2021
50 pages
Investigation Report on China's Octreotide Market 2021-2025
US$ 2,600.00
Octreotide is a derivative of artificially modified natural somatostatin, which is an octapeptide. Its physiological effects include inhibiting growth hormone function, inhibiting the secretion of gas...
July 2021
50 pages
